Futu News reported on November 30 that the three major indices of Hong Kong stocks had mixed ups and downs. The Hang Seng Index and the National Index closed up 0.29 and 0.66% respectively, while the Hang Seng Technology Index closed down 0.27%.
By the close, Hong Kong stocks had risen 994 shares, down 834 shares, and closed at 1,142.
The specific industry performance is as follows:
In terms of sectors, the Internet of Science and Technology stocks rose more and less. Tencent rose more than 3%, Kuaishou, Xiaomi, and Baidu rose about 1%, but Station B fell close to 11%.
Most biomedical stocks rose. Heyu-B rose more than 9%, Keji Pharmaceutical-B and Junshi Biotech rose more than 7%, Hanson Pharmaceuticals rose nearly 5%, and Cinda Biotech rose more than 4%.
Some education stocks rose sharply. Guangzheng Education rose nearly 117%, Thinking Fun Education rose more than 40%, Chengshi Foreign Education rose nearly 20%, and Yuhua Education rose nearly 8%.
Domestic housing stocks generally rose. China Evergrande rose nearly 12%, Sunac China rose more than 5%, Greentown China rose more than 2%, and China Resources Land and Country Garden followed suit.
Auto stocks were sluggish. Ideal Auto fell by more than 4%, Geely Automobile by nearly 3%, Great Wall Motor by about 2%, and BYD shares and Xiaopeng Motor by about 1%.
Elsewhere, power stocks showed strong performance throughout the day. Huaneng International Electric Power rose more than 6%; most petroleum stocks, Chinese leading stocks, and Chinese brokerage stocks rose; semiconductor stocks, steel stocks, catering stocks, and domestic insurance stocks all performed poorly.
In terms of individual stocks,$TENCENT (00700.HK)$It rose more than 3%. Investment industry boss Duan Yongping said he had obtained 200,000 shares of Tencent ADR, and he said he would continue to buy it slowly.
$WISDOM EDU INTL (06068.HK)$It soared nearly 117%, with annual net profit of 163 million yuan, a year-on-year increase of 71.5%, and a final dividend of 0.05 yuan per share.
$MNSO (09896.HK)$The increase was more than 5%, and the overall performance for the first fiscal quarter reached a new high. It is expected that the high growth will continue further.
$HUANENG POWER (00902.HK)$An increase of more than 6% led the rise in electricity stocks. The electricity price mechanism in Guangdong will not be changed, which will help reduce market doubts.
$EVERG SERVICES (06666.HK)$The increase was nearly 18% in the afternoon, and the subsidiary Jinbi Property sued Evergrande Group and others to recover 2 billion yuan.
$BILIBILI-W (09626.HK)$After the results, it fell nearly 11%. Bank of America lowered its target price for the stock to 131 yuan, and the balance of payments target remained unchanged.
Today's top 10 Hong Kong stock turnover
Hong Kong Stock Connect Capital
On the Hong Kong Stock Connect side, Hong Kong Stock Connect (southbound) had a net inflow of HK$1,722 million today.
Agency Perspectives
Anxin International: Maintaining the Xiaomi Group-W “buy” rating, with a target price of HK$19
Anxin International released a research report saying, maintain$XIAOMI-W (01810.HK)$“Buy” rating, target price HK$19. The 2023Q3 Group recorded total revenue of 70.89 billion yuan, a year-on-year increase of 0.6%, the first time since six quarters that it achieved a year-on-year increase in quarterly revenue; the Group's overall gross profit margin, smartphone business margin, and IoT and consumer goods business gross margin all reached record highs. The adjusted net profit was 6 billion yuan, and the profit performance exceeded market expectations.
Lyon: Maintaining Ali Health's “buy” rating, the target price was lowered to HK$5.6
According to a report published by Lyon,$ALI HEALTH (00241.HK)$The performance of the first half of fiscal year 2024 ended at the end of September was stable. Total revenue increased 13% year-on-year, and the adjusted net profit margin reached 5%. In addition, Alibaba Health acquired exclusive marketing rights for Ali Mama's healthcare category from parent company Ali, etc., at a cost of 13.5 billion yuan, including issuing new shares and cash to the parent company. Leon expects Ali Health's profit to increase significantly, but in the face of competition and macroeconomic uncertainty, most of the profits may be reinvested in growth. The bank raised Alibaba Health's 2024 and 2025 net profit forecasts by 17% and 26% respectively. Considering the impact of dilution, the target price was lowered from HK$6.4 to HK$5.6, maintaining the “buy” rating.
Goldman Sachs: Maintaining Lukfook's “buy” rating, raising target price to HK$26
Goldman Sachs published a report stating,$LUK FOOK HOLD (00590.HK)$Earnings for the first half of the fiscal year beat expectations. The dividend rate is in line with expectations. The bank raised Lukfook's net profit forecast for the 2024 to 2026 fiscal year by 7 to 13% to reflect the performance of the first half of fiscal year 2024, the improvement in retail sales growth prospects was offset by a decline in wholesale sales, and the higher gross margin retail portfolio was partially offset by increased operating expenses. The bank maintained the Lukfook “buy” rating compared to the neutral rating$CHOW TAI FOOK (01929.HK)$The bank is more optimistic about Lukfook because Lukfook better reflects strong tourist traffic from Hong Kong and Macao, and the valuation is more attractive. The target price rose slightly from HK$25.6 to HK$26.
edit/new